Drug intelligence / Profile preview

Cannatonic

Development stage
Unknown
Lead developer
Resin Seeds
Administration
Inhalation, Oral
01

Overview

**Cannatonic** is a balanced hybrid cannabis strain (50% sativa/50% indica) developed by Resin Seeds through crossing MK Ultra and G13 Haze (or variants like Reina Madre and NYC Diesel in some reports), renowned for its high CBD content (typically 12-17%) and low THC (6-8%), yielding a near 1:1 ratio that provides therapeutic relief without significant psychoactive effects. It features an earthy, woody aroma with citrus and pine notes, driven by dominant terpenes including myrcene (anti-inflammatory, sedative), limonene (mood-enhancing), beta-caryophyllene (analgesic, anxiolytic via CB2 receptor binding), linalool (anti-anxiety, anti-inflammatory), and pinene (anti-inflammatory). Primarily used medically for chronic pain, muscle spasms, migraines, inflammation (e.g., arthritis), anxiety, stress, depression, PTSD, neuropathic pain, epilepsy, and conditions like multiple sclerosis, Crohn's disease, and cancer symptoms, it induces mellow relaxation, clear-headed focus, and uplifting effects suitable for daytime use.[1][2][3][7][9]

02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Cannatonic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cannatonic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call